Adma Biologics, Inc. (ADMA)

CIK 1368514 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Adma Biologics, Inc..

Recent SEC filings

FiledFormAccession number
Aug 7, 2026SCHEDULE 13G0000093751-26-000402
Aug 5, 20268-K0001140361-26-031423
Aug 5, 202610-Q0001140361-26-031445
Jul 28, 202640001140361-26-029923
Jul 17, 202640001140361-26-028844
Jun 2, 20268-K0001140361-26-023705
May 28, 202640001140361-26-023127
May 14, 202640001140361-26-021150
May 12, 202640001140361-26-020855
May 6, 20268-K0001140361-26-019295
May 6, 202610-Q0001140361-26-019336
May 4, 20268-K0001140361-26-018667
Apr 29, 2026SCHEDULE 13G0002100119-26-000078
Apr 15, 2026DEFA14A0001140361-26-014801
Apr 15, 2026DEF 14A0001140361-26-014799
Apr 15, 2026ARS0001140361-26-014803
Apr 3, 202640001140361-26-013206
Mar 27, 20268-K0001140361-26-011569
Mar 26, 2026SCHEDULE 13G/A0000102909-26-000527
Mar 17, 202640001140361-26-009899
Mar 17, 202640001140361-26-009900
Mar 10, 202640001140361-26-008904
Mar 10, 202640001140361-26-008905
Mar 10, 20261440001140361-26-008913
Mar 9, 202640001140361-26-008363